Insights › Medicine & pharma › November 15, 2026
Medicine & pharma · Official intelligence

Singapore recalls Farganesse Injection due to particles in ampoules

Singapore Health Sciences Authority (Singapore) Published:

The Health Sciences Authority announced a Class 1 retail recall of Farganesse Injection 50mg/2ml (promethazine) due to the presence of particles in the ampoules. The recall affects specific batches distributed by FarmaMondo Pte. Ltd. and Pharm-D (Singapore) Pte. Ltd.

Original source
Read the source — hsa.gov.sg ↗

We link to the original publisher. The summary above is a short guide; read the original for the full details.

More in Medicine & pharma

See everything in Medicine & pharma →

Look into this further

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it all — start from $3No app-store installation. Cancel any time.